Preoperative rosuvastatin protects patients with coronary artery disease undergoing noncardiac surgery

Jinggang Xia1, Yang Qu, Chunlin Yin

  • 1Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, PR China.

Cardiology
|April 3, 2015
PubMed

Insights

Preoperative rosuvastatin therapy protected cardiac health in patients with coronary artery disease undergoing emergency surgery. This treatment reduced myocardial necrosis and major adverse cardiovascular and cerebrovascular events (MACCE).

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Pharmacology

Background:

  • Patients with coronary artery disease (CAD) undergoing emergency noncardiac surgery face elevated cardiovascular risks.
  • Long-term statin therapy is common in CAD patients but its perioperative role in emergency settings requires further investigation.

Purpose of the Study:

  • To determine if preoperative rosuvastatin administration could protect cardiac health in patients with CAD undergoing emergency noncardiac surgery.

Main Methods:

  • A randomized controlled trial involving 550 patients with stable CAD on long-term statin therapy undergoing emergency noncardiac surgery.
  • Patients were randomized to receive preoperative rosuvastatin or a placebo (control group).
  • All patients received rosuvastatin post-surgery; outcomes assessed included myocardial necrosis and major adverse cardiovascular and cerebrovascular events (MACCE) at 30 days and 6 months.

Main Results:

  • Lower incidence of creatinine kinase-myocardial band (CK-MB) elevations at 12 and 24 hours post-surgery in the rosuvastatin group (p = 0.029).
  • Significantly reduced incidence of MACCE in the rosuvastatin group compared to the control group (p = 0.019), primarily driven by a decrease in perioperative myocardial infarction (p = 0.029).
  • Multivariable analysis indicated a 52% reduction in MACCE incidence at 6 months with rosuvastatin reload therapy (p = 0.03).

Conclusions:

  • Preoperative rosuvastatin reload therapy is effective in reducing myocardial necrosis.
  • This strategy significantly decreases major adverse cardiovascular and cerebrovascular events (MACCE) following emergency noncardiac surgery in patients with stable CAD on long-term statin therapy.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
435
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
879
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
440
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
498
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.0K